|
TWI491606B
(zh)
|
2009-07-13 |
2015-07-11 |
Gilead Sciences Inc |
調節細胞凋亡信號之激酶的抑制劑
|
|
EP2651417B1
(en)
|
2010-12-16 |
2016-11-30 |
Calchan Limited |
Ask1 inhibiting pyrrolopyrimidine derivatives
|
|
UY34573A
(es)
|
2012-01-27 |
2013-06-28 |
Gilead Sciences Inc |
Inhibidor de la quinasa que regula la señal de la apoptosis
|
|
AU2014354769A1
(en)
|
2013-11-26 |
2016-05-26 |
Gilead Sciences, Inc. |
Therapies for treating myeloproliferative disorders
|
|
JP2017503001A
(ja)
|
2014-01-20 |
2017-01-26 |
ギリアード サイエンシーズ， インコーポレイテッド |
がんを処置するための療法
|
|
US20150342943A1
(en)
*
|
2014-06-03 |
2015-12-03 |
Gilead Sciences, Inc. |
Methods of treating liver disease
|
|
TW201618781A
(zh)
*
|
2014-08-13 |
2016-06-01 |
吉李德科學股份有限公司 |
治療肺高血壓之方法
|
|
ES2731602T3
(es)
|
2014-09-24 |
2019-11-18 |
Gilead Sciences Inc |
Métodos para tratar la enfermedad hepática
|
|
MA41252A
(fr)
*
|
2014-12-23 |
2017-10-31 |
Gilead Sciences Inc |
Formes solides d'un inhibiteur d'ask 1
|
|
CA3100432C
(en)
*
|
2014-12-23 |
2023-08-08 |
Gilead Sciences, Inc. |
Processes for preparing ask1 inhibitors
|
|
TW201639573A
(zh)
|
2015-02-03 |
2016-11-16 |
吉李德科學股份有限公司 |
有關治療癌症之合併治療
|
|
PL3321265T3
(pl)
|
2015-03-04 |
2020-11-16 |
Gilead Sciences, Inc. |
Związki 4,6-diamino-pirydo[3,2-d]pirymidynowe i ich wykorzystanie jako modulatorów receptorów toll-podobnych
|
|
IL293770B2
(en)
|
2015-07-06 |
2023-07-01 |
Gilead Sciences Inc |
Modulators of cot and methods of using them
|
|
ES2900482T3
(es)
|
2015-10-01 |
2022-03-17 |
Gilead Sciences Inc |
Combinación de un inhibidor de Btk y un inhibidor de punto de control para el tratamiento del cáncer
|
|
CA3000746A1
(en)
*
|
2015-10-02 |
2017-04-06 |
Gilead Sciences, Inc. |
Combinations of the btk inhibitor gs-4059 with inhibitors selected from a jak, ask1, brd and/or mmp9 inhibitor to treat cancer, allergic disorders, autoimmune diseases or inflammatory diseases
|
|
WO2017106556A1
(en)
|
2015-12-17 |
2017-06-22 |
Gilead Sciences, Inc. |
Tank-binding kinase inhibitor compounds
|
|
JP2019510752A
(ja)
|
2016-03-04 |
2019-04-18 |
ギリアード サイエンシーズ， インコーポレイテッド |
オートタキシン阻害剤の組成物及び合剤
|
|
CA3019003A1
(en)
|
2016-04-08 |
2017-10-12 |
Gilead Sciences, Inc. |
Compositions and methods for treating cancer, inflammatory diseases and autoimmune diseases
|
|
MY190771A
(en)
|
2016-06-13 |
2022-05-12 |
I Mab Biopharma Us Ltd |
Anti-pd-l1 antibodies and uses thereof
|
|
MA45848A
(fr)
|
2016-08-04 |
2019-06-12 |
Gilead Sciences Inc |
Cobicistat destiné à être utilisé dans des traitements du cancer
|
|
EP3507288B1
(en)
|
2016-09-02 |
2020-08-26 |
Gilead Sciences, Inc. |
4,6-diamino-pyrido[3,2-d]pyrimidine derivaties as toll like receptor modulators
|
|
CA3035346A1
(en)
|
2016-09-02 |
2018-03-08 |
Gilead Sciences, Inc. |
Toll like receptor modulator compounds
|
|
US20180133212A1
(en)
|
2016-11-03 |
2018-05-17 |
Gilead Sciences, Inc. |
Combination of a bcl-2 inhibitor and a bromodomain inhibitor for treating cancer
|
|
KR20190083655A
(ko)
|
2016-11-11 |
2019-07-12 |
길리애드 사이언시즈, 인코포레이티드 |
간 질환을 치료하는 방법
|
|
WO2018097977A1
(en)
|
2016-11-22 |
2018-05-31 |
Gilead Sciences, Inc. |
Crystalline forms of a phosphate complex of a bet inhibitor
|
|
AR110252A1
(es)
|
2016-11-30 |
2019-03-13 |
Gilead Sciences Inc |
Compuestos heterocíclicos fusionados como inhibidores de la quinasa cam
|
|
MY174821A
(en)
*
|
2017-01-22 |
2020-05-18 |
Fujian Cosunter Pharmaceutical Co Ltd |
Pyridine derivative as ask1 inhibitor and preparation method and use thereof
|
|
AU2018209573B2
(en)
*
|
2017-01-22 |
2020-08-13 |
Fujian Akeylink Biotechnology Co., Ltd. |
ASK1 inhibitor and preparation method and use thereof
|
|
JP7206193B2
(ja)
|
2017-01-24 |
2023-01-17 |
アイ－エムエービー バイオファーマ ユーエス リミテッド |
抗ｃｄ７３抗体およびその使用
|
|
AU2018224136B2
(en)
|
2017-02-24 |
2021-10-21 |
Gilead Sciences, Inc. |
Inhibitors of Bruton's Tyrosine Kinase
|
|
WO2018156901A1
(en)
|
2017-02-24 |
2018-08-30 |
Gilead Sciences, Inc. |
Inhibitors of bruton's tyrosine kinase
|
|
WO2018157277A1
(en)
|
2017-02-28 |
2018-09-07 |
Eli Lilly And Company |
Isoquinolin and naphthydrin compounds
|
|
JP7211959B2
(ja)
*
|
2017-03-03 |
2023-01-24 |
江▲蘇▼豪森▲薬▼▲業▼集▲団▼有限公司 |
アミド類誘導体阻害剤及びその製造方法と使用
|
|
JOP20180017A1
(ar)
|
2017-03-14 |
2019-01-30 |
Gilead Sciences Inc |
مثبط كيناز منظم لإشارة تلاشي خلايا
|
|
EP3600310A1
(en)
|
2017-03-28 |
2020-02-05 |
Gilead Sciences, Inc. |
Methods of treating liver disease
|
|
JP2020516627A
(ja)
|
2017-04-12 |
2020-06-11 |
ギリアード サイエンシーズ， インコーポレイテッド |
肝疾患を処置する方法
|
|
JOP20180040A1
(ar)
|
2017-04-20 |
2019-01-30 |
Gilead Sciences Inc |
مثبطات pd-1/pd-l1
|
|
EP3621615B1
(en)
|
2017-05-12 |
2023-11-15 |
Enanta Pharmaceuticals, Inc. |
Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
|
|
WO2018218051A1
(en)
*
|
2017-05-25 |
2018-11-29 |
Enanta Pharmaceuticals, Inc. |
Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
|
|
WO2018218042A1
(en)
*
|
2017-05-25 |
2018-11-29 |
Enanta Pharmaceuticals, Inc. |
Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
|
|
US10246439B2
(en)
|
2017-05-25 |
2019-04-02 |
Enanta Pharmaceuticals, Inc. |
Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
|
|
WO2018231851A1
(en)
|
2017-06-13 |
2018-12-20 |
Gilead Sciences, Inc. |
Methods of treating liver fibrosis
|
|
TW201908306A
(zh)
*
|
2017-07-18 |
2019-03-01 |
大陸商南京聖和藥業股份有限公司 |
作為ask抑制劑的雜環化合物及其應用
|
|
WO2019046186A1
(en)
|
2017-08-28 |
2019-03-07 |
Enanta Pharmaceuticals, Inc. |
INHIBITORS OF KINASE 1 REGULATING THE APOPTOTIC SIGNAL CONTAINING TETRAZOLES AND METHODS OF USE THEREOF
|
|
CN109456308B
(zh)
*
|
2017-09-06 |
2022-11-29 |
南京圣和药业股份有限公司 |
作为ask抑制剂的杂环化合物及其应用
|
|
US10370352B2
(en)
|
2017-09-07 |
2019-08-06 |
Eli Lilly And Company |
Cyclobutyl-imidazolidinone compounds
|
|
WO2019047094A1
(en)
*
|
2017-09-07 |
2019-03-14 |
Eli Lilly And Company |
CYCLOBUTYL-IMIDAZOLIDINONE COMPOUNDS
|
|
WO2019047161A1
(en)
|
2017-09-08 |
2019-03-14 |
Eli Lilly And Company |
IMIDAZOLIDINE COMPOUNDS
|
|
CN111315380A
(zh)
|
2017-09-08 |
2020-06-19 |
弗朗塞拉美国制药有限责任公司 |
凋亡信号调节激酶抑制剂及其用途
|
|
WO2019072130A1
(zh)
*
|
2017-10-12 |
2019-04-18 |
深圳市塔吉瑞生物医药有限公司 |
一种1,2,4-三氮唑类化合物
|
|
CN107793400B
(zh)
*
|
2017-10-31 |
2020-01-31 |
武汉九州钰民医药科技有限公司 |
吡啶类化合物及其在制备治疗肝脏疾病的药物中的应用
|
|
WO2019094777A1
(en)
|
2017-11-13 |
2019-05-16 |
Gilead Sciences, Inc. |
Compositions and methods for identifying and treating liver diseases and monitoring treatment outcomes
|
|
CN111566120B
(zh)
|
2017-12-20 |
2023-09-29 |
捷克共和国有机化学与生物化学研究所 |
活化sting转接蛋白的具有膦酸酯键的3’3’环状二核苷酸
|
|
JP7098748B2
(ja)
|
2017-12-20 |
2022-07-11 |
インスティチュート オブ オーガニック ケミストリー アンド バイオケミストリー エーエスシーアール，ヴイ．ヴイ．アイ． |
Ｓｔｉｎｇアダプタータンパク質を活性化するホスホン酸結合を有する２’３’環状ジヌクレオチド
|
|
US11434249B1
(en)
|
2018-01-02 |
2022-09-06 |
Seal Rock Therapeutics, Inc. |
ASK1 inhibitor compounds and uses thereof
|
|
KR102708681B1
(ko)
|
2018-02-13 |
2024-09-26 |
길리애드 사이언시즈, 인코포레이티드 |
Pd-1/pd-l1 억제제
|
|
CN110294742B
(zh)
*
|
2018-03-21 |
2023-01-31 |
山东轩竹医药科技有限公司 |
并环类ask1抑制剂及其应用
|
|
TWI818007B
(zh)
|
2018-04-06 |
2023-10-11 |
捷克科學院有機化學與生物化學研究所 |
2'3'-環二核苷酸
|
|
TW202005654A
(zh)
|
2018-04-06 |
2020-02-01 |
捷克科學院有機化學與生物化學研究所 |
２，２，─環二核苷酸
|
|
TWI833744B
(zh)
|
2018-04-06 |
2024-03-01 |
捷克科學院有機化學與生物化學研究所 |
3'3'-環二核苷酸
|
|
EP3773577B1
(en)
|
2018-04-12 |
2024-11-20 |
Terns, Inc. |
Tricyclic ask1 inhibitors
|
|
EP3781556B1
(en)
|
2018-04-19 |
2025-06-18 |
Gilead Sciences, Inc. |
Pd-1/pd-l1 inhibitors
|
|
CN110407806B
(zh)
*
|
2018-04-28 |
2021-08-17 |
深圳微芯生物科技股份有限公司 |
甲酰胺类化合物、其制备方法及其应用
|
|
US11008304B2
(en)
|
2018-05-02 |
2021-05-18 |
Enanta Pharmaceuticals, Inc. |
Tetrazole containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
|
|
WO2019213239A1
(en)
|
2018-05-02 |
2019-11-07 |
Enanta Pharmaceuticals Inc. |
Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
|
|
WO2019211799A1
(en)
|
2018-05-03 |
2019-11-07 |
Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. |
2'3'-cyclic dinucleotide analogue comprising a cyclopentanyl modified nucleotide
|
|
WO2019217780A1
(en)
|
2018-05-11 |
2019-11-14 |
Phosphorex, Inc. |
Microparticles and nanoparticles having negative surface charges
|
|
WO2019222112A1
(en)
|
2018-05-14 |
2019-11-21 |
Gilead Sciences, Inc. |
Mcl-1 inhibitors
|
|
US10654833B2
(en)
|
2018-06-28 |
2020-05-19 |
Hepatikos Therapeutics, Llc |
ASK1 isoindolin-1-one inhibitors and methods of use thereof
|
|
CN118221646A
(zh)
|
2018-07-13 |
2024-06-21 |
吉利德科学公司 |
Pd-1/pd-l1抑制剂
|
|
US11814382B2
(en)
|
2018-07-20 |
2023-11-14 |
Fujian Akeylink Biotechnology Co., Ltd. |
Crystal form as ASK1 inhibitor and preparation method and application thereof
|
|
US10968199B2
(en)
|
2018-08-22 |
2021-04-06 |
Enanta Pharmaceuticals, Inc. |
Cycloalkyl-containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
|
|
WO2020072656A1
(en)
|
2018-10-03 |
2020-04-09 |
Gilead Sciences, Inc. |
Imidozopyrimidine derivatives
|
|
KR102298546B1
(ko)
*
|
2018-10-18 |
2021-09-08 |
에이치케이이노엔 주식회사 |
신규한 n-(이소프로필-트리아졸릴)피리디닐)-헤테로아릴-카르복사미드 유도체 및 이의 용도
|
|
KR102635333B1
(ko)
|
2018-10-24 |
2024-02-15 |
길리애드 사이언시즈, 인코포레이티드 |
Pd-1/pd-l1 억제제
|
|
US11203591B2
(en)
|
2018-10-31 |
2021-12-21 |
Gilead Sciences, Inc. |
Substituted 6-azabenzimidazole compounds
|
|
US11071730B2
(en)
|
2018-10-31 |
2021-07-27 |
Gilead Sciences, Inc. |
Substituted 6-azabenzimidazole compounds
|
|
CN111170995A
(zh)
*
|
2018-11-09 |
2020-05-19 |
山东轩竹医药科技有限公司 |
Ask1抑制剂及其应用
|
|
WO2020106707A1
(en)
|
2018-11-19 |
2020-05-28 |
Enanta Pharmaceuticals, Inc. |
Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
|
|
CN109608441A
(zh)
*
|
2018-12-26 |
2019-04-12 |
都创(上海)医药科技有限公司 |
一种ask1抑制剂的合成工艺
|
|
WO2020150136A1
(en)
|
2019-01-15 |
2020-07-23 |
Gilead Sciences, Inc. |
Fxr (nr1h4) modulating compounds
|
|
CN109813915A
(zh)
*
|
2019-02-15 |
2019-05-28 |
浠思（上海）生物技术有限公司 |
利用htrf一步法筛选激酶抑制剂的方法
|
|
US11524005B2
(en)
|
2019-02-19 |
2022-12-13 |
Gilead Sciences, Inc. |
Solid forms of FXR agonists
|
|
US20220143061A1
(en)
|
2019-03-07 |
2022-05-12 |
Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. |
3'3'-cyclic dinucleotides and prodrugs thereof
|
|
WO2020178768A1
(en)
|
2019-03-07 |
2020-09-10 |
Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. |
3'3'-cyclic dinucleotide analogue comprising a cyclopentanyl modified nucleotide as sting modulator
|
|
US12318403B2
(en)
|
2019-03-07 |
2025-06-03 |
Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. |
2′3′-cyclic dinucleotides and prodrugs thereof
|
|
AU2020234929B2
(en)
|
2019-03-11 |
2023-09-14 |
Gilead Sciences, Inc. |
Formulations of a compound and uses thereof
|
|
US11466033B2
(en)
|
2019-03-25 |
2022-10-11 |
Enanta Pharmaceuticals, Inc. |
Substituted pyridines as apoptosis signal-regulating kinase 1 inhibitors
|
|
TW202212339A
(zh)
|
2019-04-17 |
2022-04-01 |
美商基利科學股份有限公司 |
類鐸受體調節劑之固體形式
|
|
TW202210480A
(zh)
|
2019-04-17 |
2022-03-16 |
美商基利科學股份有限公司 |
類鐸受體調節劑之固體形式
|
|
WO2020237025A1
(en)
|
2019-05-23 |
2020-11-26 |
Gilead Sciences, Inc. |
Substituted exo-methylene-oxindoles which are hpk1/map4k1 inhibitors
|
|
TWI770527B
(zh)
|
2019-06-14 |
2022-07-11 |
美商基利科學股份有限公司 |
Cot 調節劑及其使用方法
|
|
WO2020255038A1
(en)
|
2019-06-18 |
2020-12-24 |
Janssen Sciences Ireland Unlimited Company |
Combination of hepatitis b virus (hbv) vaccines and pyridopyrimidine derivatives
|
|
NZ783169A
(en)
|
2019-06-25 |
2024-12-20 |
Gilead Sciences Inc |
Flt3l-fc fusion proteins and methods of use
|
|
TWI855100B
(zh)
*
|
2019-06-26 |
2024-09-11 |
印度商人類製藥有限公司 |
新型細胞凋亡訊號調節激酶1抑制劑
|
|
AR119594A1
(es)
|
2019-08-09 |
2021-12-29 |
Gilead Sciences Inc |
Derivados de tienopirimidina como inhibidores acc y usos de los mismos
|
|
CN118178645A
(zh)
|
2019-10-18 |
2024-06-14 |
四十七公司 |
用于治疗骨髓增生异常综合征和急性髓系白血病的联合疗法
|
|
US20210147568A1
(en)
|
2019-10-31 |
2021-05-20 |
Forty Seven, Inc. |
Anti-cd47 based treatment of blood cancer
|
|
TWI778443B
(zh)
|
2019-11-12 |
2022-09-21 |
美商基利科學股份有限公司 |
Mcl1抑制劑
|
|
EP4058144A1
(en)
|
2019-11-15 |
2022-09-21 |
Gilead Sciences, Inc. |
Triazole carbamate pyridyl sulfonamides as lpa receptor antagonists and uses thereof
|
|
CN111018831B
(zh)
*
|
2019-11-21 |
2022-05-31 |
中国药科大学 |
细胞凋亡信号调节激酶抑制剂及其应用
|
|
WO2021133948A1
(en)
|
2019-12-23 |
2021-07-01 |
Axcella Health Inc. |
Compositions and methods for the treatment of liver diseases and disorders
|
|
LT4081305T
(lt)
|
2019-12-24 |
2024-11-25 |
Carna Biosciences, Inc. |
Diacilglicerolio kinazę moduliuojantys junginiai
|
|
TWI832035B
(zh)
|
2020-02-14 |
2024-02-11 |
美商基利科學股份有限公司 |
結合ccr8之抗體及融合蛋白及其用途
|
|
JP2023520650A
(ja)
|
2020-03-30 |
2023-05-18 |
ギリアード サイエンシーズ， インコーポレイテッド |
（Ｓ）－６－（（（１－（ビシクロ［１．１．１］ペンタン－１－イル）－１Ｈ－１，２，３－トリアゾール－４－イル）２－メチル－１－オキソ－１，２－ジヒドロイソキノリン－５－イル）メチル）））アミノ）８－クロロ－（ネオペンチルアミノ）キノリン－３－カルボニトリルＣｏｔ阻害剤化合物の固体形態
|
|
CN119390681A
(zh)
|
2020-04-02 |
2025-02-07 |
吉利德科学公司 |
用于制备cot抑制剂化合物的方法
|
|
WO2021222522A1
(en)
|
2020-05-01 |
2021-11-04 |
Gilead Sciences, Inc. |
Cd73 inhibiting 2,4-dioxopyrimidine compounds
|
|
AU2021282986B2
(en)
|
2020-06-03 |
2024-03-07 |
Gilead Sciences, Inc. |
LPA receptor antagonists and uses thereof
|
|
CN113831323B
(zh)
*
|
2020-06-24 |
2025-08-29 |
武汉人福创新药物研发中心有限公司 |
芳杂环酰胺类化合物及其用途
|
|
CN111808079A
(zh)
*
|
2020-08-05 |
2020-10-23 |
中国药科大学 |
吲哚类ask1小分子抑制剂及其制备方法和应用
|
|
CN114470217B
(zh)
*
|
2020-11-24 |
2023-06-20 |
深圳微芯生物科技股份有限公司 |
预防和治疗代谢异常或炎症引起的组织损伤的药物组合物
|
|
WO2022192428A1
(en)
|
2021-03-11 |
2022-09-15 |
Gilead Sciences, Inc. |
Glp-1r modulating compounds
|
|
US12410160B2
(en)
|
2021-03-29 |
2025-09-09 |
Gilead Sciences, Inc. |
KHK inhibitors
|
|
TW202302145A
(zh)
|
2021-04-14 |
2023-01-16 |
美商基利科學股份有限公司 |
ＣＤ４７／ＳＩＲＰα結合及ＮＥＤＤ８活化酶Ｅ１調節次單元之共抑制以用於治療癌症
|
|
CN114246866B
(zh)
*
|
2021-04-28 |
2023-09-12 |
深圳微芯生物科技股份有限公司 |
用于治疗慢性肾病的药物及其用途
|
|
AU2022273631B2
(en)
|
2021-05-11 |
2025-04-17 |
Gilead Sciences, Inc. |
Lpa receptor antagonists and uses thereof
|
|
KR20240007233A
(ko)
|
2021-05-13 |
2024-01-16 |
길리애드 사이언시즈, 인코포레이티드 |
Lpa 수용체 길항제 및 이의 용도
|
|
US20220389394A1
(en)
|
2021-05-18 |
2022-12-08 |
Gilead Sciences, Inc. |
METHODS OF USING FLT3L-Fc FUSION PROTEINS
|
|
TW202304435A
(zh)
|
2021-06-04 |
2023-02-01 |
美商基利科學股份有限公司 |
治療ｎａｓｈ之方法
|
|
TW202311256A
(zh)
|
2021-06-18 |
2023-03-16 |
美商基利科學股份有限公司 |
用於治療ｆｘｒ誘發之搔癢之ｉｌ－３１調節劑
|
|
WO2022271684A1
(en)
|
2021-06-23 |
2022-12-29 |
Gilead Sciences, Inc. |
Diacylglyercol kinase modulating compounds
|
|
CA3222595A1
(en)
|
2021-06-23 |
2022-12-29 |
Gilead Sciences, Inc. |
Diacylglyercol kinase modulating compounds
|
|
WO2022271677A1
(en)
|
2021-06-23 |
2022-12-29 |
Gilead Sciences, Inc. |
Diacylglyercol kinase modulating compounds
|
|
AU2022298639C1
(en)
|
2021-06-23 |
2025-07-17 |
Gilead Sciences, Inc. |
Diacylglyercol kinase modulating compounds
|
|
KR20240091056A
(ko)
|
2021-10-28 |
2024-06-21 |
길리애드 사이언시즈, 인코포레이티드 |
피리디진-3(2h)-온 유도체
|
|
WO2023077030A1
(en)
|
2021-10-29 |
2023-05-04 |
Gilead Sciences, Inc. |
Cd73 compounds
|
|
WO2023107954A1
(en)
|
2021-12-08 |
2023-06-15 |
Dragonfly Therapeutics, Inc. |
Antibodies targeting 5t4 and uses thereof
|
|
JP7709612B2
(ja)
|
2021-12-08 |
2025-07-16 |
ギリアード サイエンシーズ， インコーポレイテッド |
Ｌｐａ受容体アンタゴニスト及びそれらの使用
|
|
US20230203202A1
(en)
|
2021-12-08 |
2023-06-29 |
Dragonfly Therapeutics, Inc. |
Proteins binding nkg2d, cd16 and 5t4
|
|
JP2024545193A
(ja)
|
2021-12-22 |
2024-12-05 |
ギリアード サイエンシーズ， インコーポレイテッド |
Ｉｋａｒｏｓジンクフィンガーファミリー分解剤及びその使用
|
|
EP4452414A2
(en)
|
2021-12-22 |
2024-10-30 |
Gilead Sciences, Inc. |
Ikaros zinc finger family degraders and uses thereof
|
|
TW202340168A
(zh)
|
2022-01-28 |
2023-10-16 |
美商基利科學股份有限公司 |
Ｐａｒｐ７抑制劑
|
|
US12358887B2
(en)
|
2022-03-17 |
2025-07-15 |
Gilead Sciences, Inc. |
IKAROS Zinc Finger Family degraders and uses thereof
|
|
KR20240165995A
(ko)
|
2022-03-24 |
2024-11-25 |
길리애드 사이언시즈, 인코포레이티드 |
Trop-2 발현 암의 치료를 위한 병용요법
|
|
TWI876305B
(zh)
|
2022-04-05 |
2025-03-11 |
美商基利科學股份有限公司 |
用於治療結腸直腸癌之組合療法
|
|
CN119487038A
(zh)
|
2022-04-21 |
2025-02-18 |
吉利德科学公司 |
Kras g12d调节化合物
|
|
WO2024006929A1
(en)
|
2022-07-01 |
2024-01-04 |
Gilead Sciences, Inc. |
Cd73 compounds
|
|
US20240091351A1
(en)
|
2022-09-21 |
2024-03-21 |
Gilead Sciences, Inc. |
FOCAL IONIZING RADIATION AND CD47/SIRPa DISRUPTION ANTICANCER COMBINATION THERAPY
|
|
EP4638436A1
(en)
|
2022-12-22 |
2025-10-29 |
Gilead Sciences, Inc. |
Prmt5 inhibitors and uses thereof
|
|
CN115844887B
(zh)
*
|
2022-12-28 |
2023-09-08 |
中国人民解放军空军军医大学 |
Selonsertib在制备治疗癌症的药物中的用途
|
|
WO2024215754A1
(en)
|
2023-04-11 |
2024-10-17 |
Gilead Sciences, Inc. |
Kras modulating compounds
|
|
CN121079300A
(zh)
|
2023-04-21 |
2025-12-05 |
吉利德科学公司 |
Prmt5抑制剂及其用途
|
|
WO2024236595A1
(en)
*
|
2023-05-18 |
2024-11-21 |
Council Of Scientific And Industrial Research |
Protacs for ask1 protein degradation: preparation and use thereof
|
|
US20250042922A1
(en)
|
2023-06-30 |
2025-02-06 |
Gilead Sciences, Inc. |
Kras modulating compounds
|
|
WO2025024811A1
(en)
|
2023-07-26 |
2025-01-30 |
Gilead Sciences, Inc. |
Parp7 inhibitors
|
|
US20250066328A1
(en)
|
2023-07-26 |
2025-02-27 |
Gilead Sciences, Inc. |
Parp7 inhibitors
|
|
WO2025054530A1
(en)
|
2023-09-08 |
2025-03-13 |
Gilead Sciences, Inc. |
Pyrimidine-containing polycyclic derivatives as kras g12d modulating compounds
|
|
WO2025054347A1
(en)
|
2023-09-08 |
2025-03-13 |
Gilead Sciences, Inc. |
Kras g12d modulating compounds
|
|
US20250154172A1
(en)
|
2023-11-03 |
2025-05-15 |
Gilead Sciences, Inc. |
Prmt5 inhibitors and uses thereof
|
|
US20250230168A1
(en)
|
2023-12-22 |
2025-07-17 |
Gilead Sciences, Inc. |
Azaspiro wrn inhibitors
|
|
WO2025245003A1
(en)
|
2024-05-21 |
2025-11-27 |
Gilead Sciences, Inc. |
Prmt5 inhibitors and uses thereof
|